Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Crinetics Pharmaceuticals, Inc. (CRNX)

Pharmaceutical Preparations

https://www.crinetics.com

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

10222 BARNES CANYON ROAD, BLDG. #2
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/18/2018

Market Cap

4,169,854,760

Shares Outstanding

66,800,000

Weighted SO

66,799,257

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

VRDN --.--%

CYTK --.--%

GPCR --.--%

ICVX --.--%

PASG --.--%

RGNX --.--%

LIAN --.--%

KZR --.--%

Beta

0.6830

Last Div

0.0000

Range

15.76-55.78

Chg

-0.4300

Avg Vol

886666

Mkt Cap

4169854760

Exch

NASDAQ

Country

US

Phone

858 450 6464

DCF Diff

57.8038

DCF

-5.4188

Div Yield

0.0000

P/S

3010.7255

EV Multiple

-14.1299

P/FV

4.9549

Div Yield %

0.0000

P/E

-15.9214

PEG

-0.7024

Payout

0.0000

Current Ratio

16.0872

Quick Ratio

16.0872

Cash Ratio

5.5568

DSO

1344.0433

DIO

0.0000

Op Cycle

1344.0433

DPO

1837.8434

CCC

-493.8000

Gross Margin

-0.2722

Op Margin

-201.4339

Pretax Margin

-186.6715

Net Margin

-186.6715

Eff Tax Rate

0.0002

ROA

-0.2764

ROE

-0.6263

ROCE

-0.3166

NI/EBT

1.0000

EBT/EBIT

0.9267

EBIT/Rev

-201.4339

Debt Ratio

0.0570

D/E

0.0642

LT Debt/Cap

0.0523

Total Debt/Cap

0.0603

Int Coverage

0.0000

CF/Debt

-3.3446

Equity Multi

1.1261

Rec Turnover

0.2716

Pay Turnover

0.1986

Inv Turnover

0.0000

FA Turnover

0.0242

Asset Turnover

0.0015

OCF/Share

-2.2571

FCF/Share

-2.3422

Cash/Share

10.9223

OCF/Sales

-128.7560

FCF/OCF

1.0377

CF Coverage

-3.3446

ST Coverage

-23.9526

CapEx Coverage

-26.5289

Div&CapEx Cov

-26.5289

P/BV

4.9549

P/B

4.9549

P/S

3010.7255

P/E

-15.9214

P/FCF

-22.5338

P/OCF

-23.0830

P/CF

-23.0830

PEG

-0.7024

P/S

3010.7255

EV Multiple

-14.1299

P/FV

4.9549

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 11, 01:44 Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Oct 09, 03:55 Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock GlobeNewswire Inc. Jan 10, 16:33 Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Zacks Investment Research Jan 04, 03:17 Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength? Benzinga Nov 20, 10:00 8 Analysts Have This to Say About Crinetics Pharmaceuticals GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 10, 17:00 Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Benzinga Oct 24, 15:00 11 Analysts Have This to Say About Crinetics Pharmaceuticals

Revenue Product Segmentation